ChipMOS to Present at BofA Securities 2025 Asia Tech Conference

ChipMOS to Present at BofA Securities 2025 Asia Tech Conference

HSINCHU, March 13, 2025 /PRNewswire-FirstCall/ -- ChipMOS TECHNOLOGIES INC. ("ChipMOS" or the "Company") (Taiwan Stock Exchange: 8150 and Nasdaq: IMOS), an industry leading provider of outsourced semiconductor assembly and test services ("OSAT"),...

Noah to Report Fourth Quarter and Full Year 2024 Unaudited Financial Results on March 25, 2025

Noah to Report Fourth Quarter and Full Year 2024 Unaudited Financial Results on March 25, 2025

SHANGHAI, March 13, 2025 /PRNewswire/ -- Noah Holdings Limited (the "Company" or "Noah") (NYSE: NOAH and HKEX: 6686), a leading and pioneer wealth management service provider offering comprehensive advisory services on global investment and asset...

Insta360 and Leica Camera AG extend Partnership: Advancing the Action Cam Industry

Insta360 and Leica Camera AG extend Partnership: Advancing the Action Cam Industry

LOS ANGELES, March 12, 2025 /PRNewswire/ -- Insta360, a leader in 360° and action cameras, is proud to announce an extension of its partnership with Leica Camera AG, the legendary brand renowned for over a century of excellence in imaging. This...

JinkoSolar to Report Fourth Quarter and Full Year 2024 Results on March 26, 2025

JinkoSolar to Report Fourth Quarter and Full Year 2024 Results on March 26, 2025

SHANGRAO, China, March 12, 2025 /PRNewswire/ -- JinkoSolar Holding Co., Ltd. ("JinkoSolar" or the "Company") (NYSE: JKS), one of the largest and most innovative solar module manufacturers in the world, today announced that it plans to release its...

Empowering Relief Efforts: Iridium Partners with World Central Kitchen

Empowering Relief Efforts: Iridium Partners with World Central Kitchen

MCLEAN, Va., March 12, 2025 /PRNewswire/ -- Iridium Communications Inc. (Nasdaq: IRDM) a leading provider of global voice and data satellite communications, today announced a strategic partnership with World Central Kitchen (WCK), an organization...

Pierre Fabre Laboratories and RedRidge Bio Announce a Drug Discovery and Co-development Partnership

Pierre Fabre Laboratories and RedRidge Bio Announce a Drug Discovery and Co-development Partnership

CASTRES, France, CAMBRIDGE, Massachusetts and BASEL, Switzerland, March 12, 2025 /PRNewswire/ -- Pierre Fabre Laboratories and RedRidge Bio ("RedRidge") today announced an exclusive R&D collaboration and license agreement to identify and develop...

WuXi XDC and AbTis Announce Strategic Partnership to Advance Next-Generation ADCs

WuXi XDC and AbTis Announce Strategic Partnership to Advance Next-Generation ADCs

SHANGHAI and SEOUL, South Korea , March 11, 2025 /PRNewswire/ -- WuXi XDC Cayman Inc. ("WuXi XDC" or the "Company", stock code: 2268.HK), a leading global CRDMO (Contract Research, Development, and Manufacturing Organization) specializing in...

Optty names veterans payment leader Steven Ritchie as Acting CEO during strategic leadership transition

Optty names veterans payment leader Steven Ritchie as Acting CEO during strategic leadership transition

SINGAPORE, March 11, 2025 /PRNewswire/ -- Optty ™, leading global payments technology company headquartered in Singapore is excited to announce its plans to build out its executive leadership team as it continues to deliver on its significant global...

The Channel Company Welcomes Athina Mallis as Editor of CRN Australia

The Channel Company Welcomes Athina Mallis as Editor of CRN Australia

WESTBOROUGH, Mass., March 11, 2025 /PRNewswire/ -- The Channel Company, a global provider of news, insights, strategy, events, and marketing services for the information technology industry, is delighted to announce the appointment of Athina Mallis...

Harbour BioMed Appoints Michael D. Patten as Chief Strategy Officer

Harbour BioMed Appoints Michael D. Patten as Chief Strategy Officer

CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SHANGHAI, March 11, 2025 /PRNewswire/ -- Harbour BioMed (HKEX: 02142), a global biopharmaceutical company committed to the discovery, development and commercialization of novel antibody therapeutics...

  • 1
  • ...
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • ...
  • 53
  • menu
    menu